Author: Fatima Jabri

Zahrawi Group is proud to announce that our Nuclear Medicine Team successfully supplied the first case of Lutetium Therapy in Oman using products from our partner ITM. This significant milestone not only reinforces our commitment to advancing healthcare solutions but also places us at the forefront of nuclear medicine therapy in the region.

Lutetium, a rare and invaluable therapeutic nuclide, holds immense promise in the treatment of cancer patients. Zahrawi Group is honored to be the first to introduce this cutting-edge therapy to Oman, in collaboration with the esteemed Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC), a State-of-the-Art Healthcare facility.

Our dedicated team, with invaluable support from local regulatory authorities, worked tirelessly for the completion of this project and to ensure a successful introduction of Lutetium Therapy, which will bring a significant transformation in the medical landscape of Oman, presenting novel and effective treatment alternatives for cancer patients.

Zahrawi Group remains steadfast in its mission to bring cutting-edge healthcare solutions to the region, and we would like to thank our partners #ITM & #LEVALIS for making this achievement possible.

Zahrawi Group – Qatar Lab Division had a successful participation in the 34th Annual Congress of the International Academy of Pathology – Arab Division (IAP-AD) held from November 30th to December 3rd, 2023, in Doha.

IAP-AD Congress provides a platform to highlight innovative research, share valuable insights, and contribute to the advancement of the field of pathology. With a wide range of topics, including but not limited to, Diagnostic Pathology, Digital Pathology, Artificial Intelligence, Emerging Technologies, Precision Medicine, Hematopathology, Oncology, Pathology Education and Quality Assurance.

As part of our dedication to knowledge-sharing and advancing scientific understanding, our team hosted a workshop in collaboration with Agilent. The workshop, PD-L1 – Combined Positive Score (CPS) in various indications, was attended by brilliant minds, and expertise from all over the world.

Zahrawi Group recognizes the profound importance of participating in conferences like (IAP-AD) which was held for the first time in Qatar, showing our commitment to being at the forefront of transformative technologies and help in the develop of our community.

Our active involvement in this event perfectly aligns with our overarching strategy and vision, we are proud to have contributed to the success of this event by joining pathologists in their journey to improve people’s lives in the field of pathology and life sciences.